Monocyte Distribution Width (MDW) as a biomarker of sepsis: An evidenced-based laboratory medicine approach.
Clin Chim Acta
; 540: 117214, 2023 Feb 01.
Article
Dans Anglais
| MEDLINE | ID: covidwho-2239827
ABSTRACT
Monocyte Distribution Width (MDW) is a new generation cell blood count parameter providing a measure of monocyte anisocytosis. In the last decades, it has emerged as a reliable biomarker of sepsis in the acute setting, especially emergency department, and intensive care unit. MDW has several advantages over commonly used sepsis biomarkers, including low-cost, ease and speed of measurement. The clinical usefulness of MDW has been established in several studies and some clinical laboratory medicines have already implemented it in their routine. In this article, we describe the analytical and clinical features of MDW to guide its appropriate use in clinical practice by integrating the research evidence with real-world laboratory experience. The proper use of a biomarker is critical for improving patients' care and outcome as well as ensuring healthcare quality.
Mots clés
Texte intégral:
Disponible
Collection:
Bases de données internationales
Base de données:
MEDLINE
Sujet Principal:
Monocytes
/
Sepsie
Type d'étude:
Étude diagnostique
/
Étude pronostique
Limites du sujet:
Humains
langue:
Anglais
Revue:
Clin Chim Acta
Année:
2023
Type de document:
Article
Pays d'affiliation:
J.cca.2022.117214
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS